Summary
In an interdisciplinary prospective study 50 patients surgically treated for breast cancer were treated with six monthly courses of aggressive adjuvant chemotherapy (adriamycin and cyclophosphamide) and were randomized to receive either immunotherapy with levamisole or no additional therapy. Probability of disease-free survival for the whole group is 54.9% at 42 months. There was no noticeable difference in disease-free survival for either pre- and postmenopausal women or for patients treated with or without levamisole. The addition of levamisole had no effect on the depression of in vitro immunologic functions during chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Betzier M, Schlag P, Schreml W, Herfarth C (1978) Mammakarzinom: Stadieneinteilung, Therapie und Nachsorge. Med Klin 73:633
Betzier M, Flad HD, Schreml W, et al. (1979) Quantitative and functional studies of lymphocyte subpopulations during adjuvant chemo(immuno)therapy in patients with breast cancer. In: Flad HD, Herfarth Ch, Betzler M (eds) Immunodiagnosis and immunotherapy of malignant tumors. Springer, Berlin Heidelberg New York
Bonadonna G, Brusamolino E, Valagussa P, et al. (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 405
Bonadonna G, Valagussa P, Rossi A, et al. (1978) Are adjuvant trials altering the course of breast cancer? Semin Oncol 5:450–464
Fisher B, Carbone P, Economon SG, et al. (1975) l-Phenylalanine mustard (l-PAM) in the management of primary breast cancer: A report of early findings. N Engl J Med 292:117
Flad HD, Betzier M, Schreml W, et al. (1978) Verhalten lymphatischer Subpopulationen unter zytostatischer Therapie. In: Huber H, Senn HJ, Falkensammer M (eds) Adjuvante zytostatische Chemotherapie. Zytostatische Therapie als Rezidivprophylaxe? Hämatologie und Bluttransfusion, vol 22. Springer, Berlin Heidelberg New York, S 25
Immich H (1977) Medizinische Statistik. Schattauer, Stuttgart
Rojas AF, Mickiewicz E, Feierstein JN, Glait H, Olivari AJ (1976) Levamisole in advanced human breast cancer. Lancet 1:211
Wendt AG, Jones SE, Salmon SE, et al. (1979) Adjuvant treatment of breast cancer with adriamycin-cyclophosphamide with or without radiation therapy. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer II. Grune & Stratton, New York, pp 63–70
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Betzler, M. et al. (1982). Adjuvant Intermittent Chemoimmunotherapy for Primary Breast Cancer: A Prospective Study with Immunologic Follow-Up. In: Mathé, G., Bonadonna, G., Salmon, S. (eds) Adjuvant Therapies of Cancer. Recent Results in Cancer Research, vol 80. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81685-7_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-81685-7_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81687-1
Online ISBN: 978-3-642-81685-7
eBook Packages: Springer Book Archive